A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above
Clinical trial NCT04510207 · COMPLETED
Trial details
- NCT number
- NCT04510207
- Sponsor
- China National Biotec Group Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-16
- Primary completion
- 2021-06-16
- Enrollment
- 44101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.